PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual...

38

Transcript of PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual...

Page 1: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 2: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 3: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 4: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 5: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 6: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 7: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma

Κ λ

Κ λ Κλ

Page 8: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 9: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 10: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 11: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 12: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 13: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 14: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 15: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 16: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 17: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 18: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 19: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 20: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 21: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 22: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 23: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 24: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 25: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 26: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 27: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 28: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 29: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 30: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 31: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 32: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma

•

1. Morgan et al (2012) Blood 119(1): 7-15

2. Rawstron (2013) JCO 31(20): 2540-7

Page 33: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 34: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 35: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 36: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 37: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma
Page 38: PowerPoint Presentation · PDF filePolymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma

Land surface processes and monsoon climate system · Part 2: Run a 16-member ensemble, with each member forced to maintain the same time series of surface prognostic variables (Simulations

Land surface processes and monsoon climate system · Part 2: Run a 16-member ensemble, with each member forced to maintain the same time series of surface prognostic variables (Simulations

CLINICAL PROGNOSTIC VALUES IN HAMSTRING INJ...following two hamstring strengthening exercises Jurdan Mendiguchia 1 , Mirian Aranzazu Garrues 2 , John Barry Cronin 3,4 , Bret Contreras

CLINICAL PROGNOSTIC VALUES IN HAMSTRING INJ...following two hamstring strengthening exercises Jurdan Mendiguchia 1 , Mirian Aranzazu Garrues 2 , John Barry Cronin 3,4 , Bret Contreras

IT Sicherheit: Kryptologie · I Kryptographie: altgriechisch ... 6.3 >1010 = 10 Mrd. Jahre Dr. Christian Rathgeb IT-Sicherheit, Kapitel 2 / 22.04.2020 15/159. ... e e e n n e e n

IT Sicherheit: Kryptologie · I Kryptographie: altgriechisch ... 6.3 >1010 = 10 Mrd. Jahre Dr. Christian Rathgeb IT-Sicherheit, Kapitel 2 / 22.04.2020 15/159. ... e e e n n e e n

Prognostic Parameters for Therapy Study of HIV Infections · J. R. Bogner, F.-D. Goebel Lymphocyte Subsets as Surrogate Markers in Antiretroviral Therapy Summary: Efficacy of antiretroviral

Prognostic Parameters for Therapy Study of HIV Infections · J. R. Bogner, F.-D. Goebel Lymphocyte Subsets as Surrogate Markers in Antiretroviral Therapy Summary: Efficacy of antiretroviral

Large-scale pan-cancer analysis reveals broad prognostic ......2019/08/08  · 2Institut Curie, PSL Research University, INSERM U1021, CNRS UMR3347, Team “TGF-ß and Oncogenesis“,

Large-scale pan-cancer analysis reveals broad prognostic ......2019/08/08  · 2Institut Curie, PSL Research University, INSERM U1021, CNRS UMR3347, Team “TGF-ß and Oncogenesis“,

Prognostic roles of pathology markers immunoexpression and ...

Prognostic roles of pathology markers immunoexpression and ...

Long Noncoding RNA miR503HG, a Prognostic Indicator ...Inhibits Tumor Metastasis by Regulating The ... transverse incision in the upper abdomen, each nude mouse was inoculated orthotopically

Long Noncoding RNA miR503HG, a Prognostic Indicator ...Inhibits Tumor Metastasis by Regulating The ... transverse incision in the upper abdomen, each nude mouse was inoculated orthotopically

Myeloma and Transplant Sergio A Giralt, MD Chief, Adult Bone Marrow Transplant Service Division of Hematologic Oncology Department of Medicine Memorial.

Myeloma and Transplant Sergio A Giralt, MD Chief, Adult Bone Marrow Transplant Service Division of Hematologic Oncology Department of Medicine Memorial.

Oridonin Induces Apoptosis of Myeloma Cells by Inducing C-Myc … · 2017-11-30 · Citation: Takano M, Nishiya M, Kowata S, Ishida Y, Ito S. Oridonin Induces Apoptosis of Myeloma

Oridonin Induces Apoptosis of Myeloma Cells by Inducing C-Myc … · 2017-11-30 · Citation: Takano M, Nishiya M, Kowata S, Ishida Y, Ito S. Oridonin Induces Apoptosis of Myeloma

Original Article Clinical and prognostic significance of ...Abstract: Gliomas are the most common brain tumors, leading to significant cancer-related mortality worldwide. Hypoxia-inducible

Original Article Clinical and prognostic significance of ...Abstract: Gliomas are the most common brain tumors, leading to significant cancer-related mortality worldwide. Hypoxia-inducible

Multiple Myeloma Dimas

Multiple Myeloma Dimas

Pirh2 mediates the sensitivity of myeloma cells to ... · Multiple Myeloma Treatment Center & Bone Marrow Transplantation Center, The First Affiliated Hospital, College of Medicine,

Pirh2 mediates the sensitivity of myeloma cells to ... · Multiple Myeloma Treatment Center & Bone Marrow Transplantation Center, The First Affiliated Hospital, College of Medicine,

Research Paper Clinicopathologic and Prognostic …7. Department of Biotechnology, Chia Nan University of Pharmacy and Science, Tainan, Taiwan Corresponding author: Chia-Lang Fang,

Research Paper Clinicopathologic and Prognostic …7. Department of Biotechnology, Chia Nan University of Pharmacy and Science, Tainan, Taiwan Corresponding author: Chia-Lang Fang,

RV function Prognostic implications in heart failure

RV function Prognostic implications in heart failure

Long noncoding RNA UCA1 promotes multiple myeloma cell ... · The exploration of a novel functional mo- ... the progress of MM development. For instance, lncRNA MALAT1 functions as

Long noncoding RNA UCA1 promotes multiple myeloma cell ... · The exploration of a novel functional mo- ... the progress of MM development. For instance, lncRNA MALAT1 functions as

Ref: CYT-MM-MRD - Amazon S3 · Ref: CYT-MM-MRD For research use ... ( λ) light chain staining may be helpful to clarify atypical findings in ... l of cell suspension should remain

Ref: CYT-MM-MRD - Amazon S3 · Ref: CYT-MM-MRD For research use ... ( λ) light chain staining may be helpful to clarify atypical findings in ... l of cell suspension should remain

The fi rst report of myeloma with IgD κ and free κ in Indonesia

The fi rst report of myeloma with IgD κ and free κ in Indonesia

Diagnostic and Prognostic performance of blood plasma glycan … · 2019-02-26 · Recently, we have applied glycan node analysis to several cancer studies, including pancreatic 3,

Diagnostic and Prognostic performance of blood plasma glycan … · 2019-02-26 · Recently, we have applied glycan node analysis to several cancer studies, including pancreatic 3,

THE EVICTION STUDY - Imcheck Therapeutics · 2020. 11. 5. · REFERENCES. 1. Gentles AJ, Newman AM, Liu CL, et al. The prognostic landscape of genes and infiltrating immune cells

THE EVICTION STUDY - Imcheck Therapeutics · 2020. 11. 5. · REFERENCES. 1. Gentles AJ, Newman AM, Liu CL, et al. The prognostic landscape of genes and infiltrating immune cells

Carfilzomib for PTCL 28, 2015/05... · 2017-03-01 · Biologic Prognostic Markers in PTCL Prognostic Marker Outcome EBV + Unfavorable Ki-67% > 80 Unfavorable Cytotoxic granule expression

Carfilzomib for PTCL 28, 2015/05... · 2017-03-01 · Biologic Prognostic Markers in PTCL Prognostic Marker Outcome EBV + Unfavorable Ki-67% > 80 Unfavorable Cytotoxic granule expression